BRWD3_HUMAN - dbPTM
BRWD3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BRWD3_HUMAN
UniProt AC Q6RI45
Protein Name Bromodomain and WD repeat-containing protein 3
Gene Name BRWD3
Organism Homo sapiens (Human).
Sequence Length 1802
Subcellular Localization
Protein Description Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape..
Protein Sequence MAAAPTQIEAELYYLIARFLQSGPCNKSAQVLVQELEEHQLIPRRLDWEGKEHRRSFEDLVAANAHIPPDYLLKICERIGPLLDKEIPQSVPGVQTLLGVGRQSLLRDAKDCKSTLWNGSAFAALHRGRPPELPVNYVKPPNVVNITSARQLTGCSRFGHIFPSSAYQHIKMHKRILGHLSSVYCVAFDRSGRRIFTGSDDCLVKIWATDDGRLLATLRGHSAEISDMAVNYENTLIAAGSCDKVVRVWCLRTCAPVAVLQGHSASITSIQFCPSTKGTNRYLTSTGADGTICFWQWHVKTMKFRDRPVKFTERSRPGVQISCSSFSSGGMFITTGSTDHVIRIYYLGSEVPEKIAELESHTDKVVAVQFCNNGDSLRFVSGSRDGTARIWQYQQQEWKSIVLDMATKMTGNNLPSGEDKITKLKVTMVAWDRYDTTVITAVNNFLLKVWNSITGQLLHTLSGHDDEVFVLEAHPFDQRIILSAGHDGNIFIWDLDRGTKIRNYFNMIEGQGHGAVFDCKFSPDGNHFACTDSHGHLLLFGFGCSKYYEKIPDQMFFHTDYRPLIRDANNYVLDEQTQQAPHLMPPPFLVDVDGNPHPTKFQRLVPGRENCKDEQLIPQLGYVANGDGEVVEQVIGQQTNDQDESILDGIIRELQREQDLRLINEGDVPHLPVNRAYSVNGALRSPNMDISSSPNIRLRRHSSQIEGVRQMHNNAPRSQMATERDLMAWSRRVVVNELNNGVSRVQEECRTAKGDIEISLYTVEKKKKPSYTTQRNDYEPSCGRSLRRTQRKRQHTYQTRSNIEHNSQASCQNSGVQEDSDSSSEEDETVGTSDASVEDPVVEWQSESSSSDSSSEYSDWTADAGINLQPPKRQTRQTTRKICSSSDEENLKSLEERQKKPKQTRKKKGGLVSIAGEPNEEWFAPQWILDTIPRRSPFVPQMGDELIYFRQGHEAYVRAVRKSKIYSVNLQKQPWNKMDLREQEFVKIVGIKYEVGPPTLCCLKLAFLDPISGKMTGESFSIKYHDMPDVIDFLVLHQFYNEAKERNWQIGDRFRSIIDDAWWFGTVESQQPFQPEYPDSSFQCYSVHWDNNEREKMSPWDMEPIPEGTAFPDEVGAGVPVSQEELTALLYKPQEGEWGAHSRDEECERVIQGINHLLSLDFASPFAVPVDLSAYPLYCTVVAYPTDLNTIRRRLENRFYRRISALMWEVRYIEHNARTFNEPDSPIVKAAKIVTDVLLRFIGDQSCTDILDTYNKIKAEERNSTDAEEDTEIVDLDSDGPGTSSGRKVKCRGRRQSLKCNPDAWKKQCKELLSLIYEREDSEPFRQPADLLSYPGHQEQEGESSESVVPERQQDSSLSEDYQDVIDTPVDFSTVKETLEAGNYGSPLEFYKDVRQIFNNSKAYTSNKKSRIYSMMLRLSALFESHIKNIISEYKSAIQSQKRRRPRYRKRLRSSSSSLSSSGAPSPKGKQKQMKLQPKNDQNTSVSHARTSSPFSSPVSDAAEGLSLYLLDDEPDGPFSSSSFGGYSRSGNSHDPGKAKSFRNRVLPVKQDHSLDGPLTNGDGREPRTGIKRKLLSASEEDENMGGEDKEKKETKEKSHLSTSESGELGSSLSSESTCGSDSDSESTSRTDQDYVDGDHDYSKFIQTRPKRKLRKQHGNGKRNWKTRGTGGRGRWGRWGRWSRGGRGRGGRGRGSRGRGGGGTRGRGRGRGGRGASRGATRAKRARIADDEFDTMFSGRFSRLPRIKTRNQGRRTVLYNDDSDNDNFVSTEDPLNLGTSRSGRVRKMTEKARVSHLMGWNY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MAAAPTQIEAELY
--CCCCCCHHHHHHH
37.14-
13PhosphorylationTQIEAELYYLIARFL
CHHHHHHHHHHHHHH
6.4227422710
14PhosphorylationQIEAELYYLIARFLQ
HHHHHHHHHHHHHHH
12.3127422710
104PhosphorylationLLGVGRQSLLRDAKD
HHCCCHHHHHHCHHH
28.1924719451
171AcetylationSSAYQHIKMHKRILG
CHHHHHHHHHHHHHH
32.5925953088
268PhosphorylationQGHSASITSIQFCPS
CCCCCEEEEEEECCC
19.7920058876
312PhosphorylationRDRPVKFTERSRPGV
CCCCCCCCCCCCCCC
25.4430576142
315PhosphorylationPVKFTERSRPGVQIS
CCCCCCCCCCCCEEE
36.2730576142
334PhosphorylationSSGGMFITTGSTDHV
CCCCEEEECCCCCCE
17.5328450419
335PhosphorylationSGGMFITTGSTDHVI
CCCEEEECCCCCCEE
25.0728450419
337PhosphorylationGMFITTGSTDHVIRI
CEEEECCCCCCEEEE
28.6828450419
338PhosphorylationMFITTGSTDHVIRIY
EEEECCCCCCEEEEE
31.3128450419
360PhosphorylationEKIAELESHTDKVVA
HHHHHHHHCCCCEEE
44.2930576142
362PhosphorylationIAELESHTDKVVAVQ
HHHHHHCCCCEEEEE
46.9630576142
546AcetylationLFGFGCSKYYEKIPD
EEECCCHHHHHHCCC
56.8025953088
577PhosphorylationNYVLDEQTQQAPHLM
CCCCCCCCCCCCCCC
22.17-
583UbiquitinationQTQQAPHLMPPPFLV
CCCCCCCCCCCCEEE
5.5521890473
583UbiquitinationQTQQAPHLMPPPFLV
CCCCCCCCCCCCEEE
5.5521890473
583 (in isoform 3)Ubiquitination-5.5521890473
588UbiquitinationPHLMPPPFLVDVDGN
CCCCCCCEEEECCCC
14.8422817900
677PhosphorylationHLPVNRAYSVNGALR
CCCCCCEEEECCCCC
15.2023186163
678PhosphorylationLPVNRAYSVNGALRS
CCCCCEEEECCCCCC
14.2327067055
685PhosphorylationSVNGALRSPNMDISS
EECCCCCCCCCCCCC
22.8323403867
691PhosphorylationRSPNMDISSSPNIRL
CCCCCCCCCCCCHHH
22.0923403867
692PhosphorylationSPNMDISSSPNIRLR
CCCCCCCCCCCHHHH
50.5823403867
693PhosphorylationPNMDISSSPNIRLRR
CCCCCCCCCCHHHHH
18.3823403867
702PhosphorylationNIRLRRHSSQIEGVR
CHHHHHCHHHHHHHH
23.3330266825
703PhosphorylationIRLRRHSSQIEGVRQ
HHHHHCHHHHHHHHH
29.1117525332
816 (in isoform 4)Ubiquitination-5.9021890473
816 (in isoform 2)Ubiquitination-5.9021890473
816UbiquitinationASCQNSGVQEDSDSS
HHHCCCCCCCCCCCC
5.9021890473
884PhosphorylationQTTRKICSSSDEENL
HHHHHHHCCCCHHHH
36.0323663014
885PhosphorylationTTRKICSSSDEENLK
HHHHHHCCCCHHHHH
37.0823663014
886PhosphorylationTRKICSSSDEENLKS
HHHHHCCCCHHHHHH
32.5223663014
893PhosphorylationSDEENLKSLEERQKK
CCHHHHHHHHHHHHC
44.1528787133
937UbiquitinationDTIPRRSPFVPQMGD
HCCCCCCCCCCCCCC
32.2321890473
942UbiquitinationRSPFVPQMGDELIYF
CCCCCCCCCCEEEEE
6.3022817900
948PhosphorylationQMGDELIYFRQGHEA
CCCCEEEEEECCHHH
12.82-
964UbiquitinationVRAVRKSKIYSVNLQ
HHHHHHHCEEEEECC
49.0129967540
987 (in isoform 1)Ubiquitination-36.6721890473
987UbiquitinationLREQEFVKIVGIKYE
CCHHHHHEEECEEEE
36.6722817900
987 (in isoform 5)Ubiquitination-36.6721890473
992UbiquitinationFVKIVGIKYEVGPPT
HHEEECEEEEECCCC
29.4522817900
1019PhosphorylationSGKMTGESFSIKYHD
CCCCCCCCEEEEECC
26.1624719451
1021PhosphorylationKMTGESFSIKYHDMP
CCCCCCEEEEECCCC
27.7024719451
1024PhosphorylationGESFSIKYHDMPDVI
CCCEEEEECCCCCHH
11.03-
1040PhosphorylationFLVLHQFYNEAKERN
HHHHHHHHHHHHHHC
12.91-
1225PhosphorylationRTFNEPDSPIVKAAK
CCCCCCCCHHHHHHH
27.5224719451
1246PhosphorylationLRFIGDQSCTDILDT
HHHHCCCCHHHHHHH
24.5923828894
1253PhosphorylationSCTDILDTYNKIKAE
CHHHHHHHHHHHHHH
26.0823828894
1254PhosphorylationCTDILDTYNKIKAEE
HHHHHHHHHHHHHHH
17.7123828894
1256UbiquitinationDILDTYNKIKAEERN
HHHHHHHHHHHHHHC
34.8629967540
1264PhosphorylationIKAEERNSTDAEEDT
HHHHHHCCCCCCCCC
33.6121406692
1265PhosphorylationKAEERNSTDAEEDTE
HHHHHCCCCCCCCCE
42.6621406692
1271PhosphorylationSTDAEEDTEIVDLDS
CCCCCCCCEEEECCC
30.7821406692
1278PhosphorylationTEIVDLDSDGPGTSS
CEEEECCCCCCCCCC
52.3321406692
1283PhosphorylationLDSDGPGTSSGRKVK
CCCCCCCCCCCCEEE
23.8921406692
1284PhosphorylationDSDGPGTSSGRKVKC
CCCCCCCCCCCEEEE
36.3921406692
1285PhosphorylationSDGPGTSSGRKVKCR
CCCCCCCCCCEEEEC
42.3221406692
1386PhosphorylationLEAGNYGSPLEFYKD
HHCCCCCCCHHHHHH
18.8925159151
1402MethylationRQIFNNSKAYTSNKK
HHHHHCCCCCCCCCH
47.76-
1402"N6,N6-dimethyllysine"RQIFNNSKAYTSNKK
HHHHHCCCCCCCCCH
47.76-
1404PhosphorylationIFNNSKAYTSNKKSR
HHHCCCCCCCCCHHH
17.90-
1405PhosphorylationFNNSKAYTSNKKSRI
HHCCCCCCCCCHHHH
30.59-
1406PhosphorylationNNSKAYTSNKKSRIY
HCCCCCCCCCHHHHH
33.69-
1410PhosphorylationAYTSNKKSRIYSMML
CCCCCCHHHHHHHHH
26.0627174698
1413PhosphorylationSNKKSRIYSMMLRLS
CCCHHHHHHHHHHHH
6.87-
1414PhosphorylationNKKSRIYSMMLRLSA
CCHHHHHHHHHHHHH
8.7127174698
1450UbiquitinationRRRPRYRKRLRSSSS
HCCHHHHHHHHHCCC
47.02-
1454PhosphorylationRYRKRLRSSSSSLSS
HHHHHHHHCCCCCCC
38.8820068231
1455PhosphorylationYRKRLRSSSSSLSSS
HHHHHHHCCCCCCCC
28.0120068231
1456PhosphorylationRKRLRSSSSSLSSSG
HHHHHHCCCCCCCCC
25.7820068231
1457PhosphorylationKRLRSSSSSLSSSGA
HHHHHCCCCCCCCCC
36.9320068231
1458PhosphorylationRLRSSSSSLSSSGAP
HHHHCCCCCCCCCCC
33.9320068231
1460PhosphorylationRSSSSSLSSSGAPSP
HHCCCCCCCCCCCCC
25.1420068231
1461PhosphorylationSSSSSLSSSGAPSPK
HCCCCCCCCCCCCCC
37.7820068231
1462PhosphorylationSSSSLSSSGAPSPKG
CCCCCCCCCCCCCCC
35.2820068231
1466PhosphorylationLSSSGAPSPKGKQKQ
CCCCCCCCCCCCCCC
38.4220068231
1491PhosphorylationTSVSHARTSSPFSSP
CCCHHCCCCCCCCCC
34.0528348404
1492PhosphorylationSVSHARTSSPFSSPV
CCHHCCCCCCCCCCC
30.3828348404
1493PhosphorylationVSHARTSSPFSSPVS
CHHCCCCCCCCCCCC
29.3828348404
1569PhosphorylationGDGREPRTGIKRKLL
CCCCCCCCCHHHHHH
54.7117081983
1577PhosphorylationGIKRKLLSASEEDEN
CHHHHHHCCCHHHHC
39.9425159151
1579PhosphorylationKRKLLSASEEDENMG
HHHHHCCCHHHHCCC
37.8425159151
1599PhosphorylationKKETKEKSHLSTSES
HHHHHHHHCCCCCCC
30.65-
1603PhosphorylationKEKSHLSTSESGELG
HHHHCCCCCCCCCCC
42.76-
1606PhosphorylationSHLSTSESGELGSSL
HCCCCCCCCCCCCCC
37.02-
1611PhosphorylationSESGELGSSLSSEST
CCCCCCCCCCCCCCC
40.50-
1612PhosphorylationESGELGSSLSSESTC
CCCCCCCCCCCCCCC
30.39-
1740MethylationFDTMFSGRFSRLPRI
HHHHHCCCCCCCCCE
25.76-
1743MethylationMFSGRFSRLPRIKTR
HHCCCCCCCCCEECC
46.10-
1756PhosphorylationTRNQGRRTVLYNDDS
CCCCCCCEEEECCCC
17.3223663014
1759PhosphorylationQGRRTVLYNDDSDND
CCCCEEEECCCCCCC
16.5323663014
1763PhosphorylationTVLYNDDSDNDNFVS
EEEECCCCCCCCCCC
40.9730175587
1770PhosphorylationSDNDNFVSTEDPLNL
CCCCCCCCCCCCCCC
23.1827251275
1771PhosphorylationDNDNFVSTEDPLNLG
CCCCCCCCCCCCCCC
38.8227251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BRWD3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BRWD3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BRWD3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of BRWD3_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
Note=A chromosomal aberration involving BRWD3 can be found in patients with B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(X
11)(q21
q23) with ARHGAP20 does not result in fusion transcripts but disrupts both genes.
300659
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BRWD3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-703, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1455 AND SER-1466, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1569, AND MASSSPECTROMETRY.

TOP